Healthpeak Properties (NYSE:DOC - Get Free Report) had its target price lowered by equities research analysts at Mizuho from $24.00 to $23.00 in a research report issued on Monday, Benzinga reports. The brokerage presently has an "outperform" rating on the real estate investment trust's stock. Mizuho's target price points to a potential upside of 16.49% from the stock's previous close.
Several other equities analysts also recently issued reports on DOC. Wells Fargo & Company upped their target price on Healthpeak Properties from $19.00 to $20.00 and gave the company an "equal weight" rating in a research report on Monday. Citigroup raised their price objective on Healthpeak Properties from $20.00 to $22.00 and gave the company a "neutral" rating in a report on Tuesday, August 11th. Cantor Fitzgerald lowered their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set a "neutral" rating on the stock in a research note on Wednesday, November 4th. Barclays cut their target price on Healthpeak Properties from $24.00 to $21.00 and set an "equal weight" rating for the company in a research note on Tuesday, October 13th. Finally, Robert W. Baird increased their price target on Healthpeak Properties from $21.00 to $24.00 and gave the stock an "outperform" rating in a report on Thursday, August 13th. Four analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $21.60.
Read Our Latest Analysis on DOC
Healthpeak Properties Stock Down 1.2%
NYSE:DOC traded down $0.23 during mid-day trading on Monday, hitting $19.75. 1,420,393 shares of the company's stock traded hands, compared to its average volume of 7,588,708. The company has a fifty day moving average of $19.68 and a 200 day moving average of $19.26. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.29 and a current ratio of 1.29. Healthpeak Properties has a twelve month low of $15.70 and a twelve month high of $22.95. The company has a market capitalization of $13.62 billion, a P/E ratio of 36.58, a P/E/G ratio of 2.46 and a beta of 1.01.
Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its quarterly earnings results on Monday, November 2nd. The real estate investment trust reported $0.02 earnings per share for the quarter, missing analysts' consensus estimates of $0.43 by ($0.41). The business had revenue of $820.89 million for the quarter, compared to analysts' expectations of $739.18 million. Healthpeak Properties had a return on equity of 4.04% and a net margin of 12.32%. Healthpeak Properties's revenue was up 16.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.46 EPS. On average, analysts forecast that Healthpeak Properties will post 1.77 EPS for the current year.
Insider Activity
In other Healthpeak Properties news, EVP Ankit Patadia sold 6,115 shares of the stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $20.78, for a total transaction of $127,069.70. Following the completion of the sale, the executive vice president directly owned 2,838 shares of the company's stock, valued at approximately $58,973.64. This trade represents a 68.30% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.23% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Healthpeak Properties
Institutional investors have recently added to or reduced their stakes in the business. OneDigital Investment Advisors LLC lifted its holdings in Healthpeak Properties by 3.3% in the second quarter. OneDigital Investment Advisors LLC now owns 15,376 shares of the real estate investment trust's stock valued at $329,000 after acquiring an additional 493 shares during the period. Clearstead Trust LLC grew its position in Healthpeak Properties by 66.7% during the second quarter. Clearstead Trust LLC now owns 1,357 shares of the real estate investment trust's stock valued at $29,000 after buying an additional 543 shares during the period. Bessemer Group Inc. raised its position in shares of Healthpeak Properties by 32.1% in the third quarter. Bessemer Group Inc. now owns 2,404 shares of the real estate investment trust's stock worth $48,000 after acquiring an additional 584 shares during the period. North Dakota State Investment Board boosted its stake in shares of Healthpeak Properties by 3.0% during the 3rd quarter. North Dakota State Investment Board now owns 21,239 shares of the real estate investment trust's stock worth $424,000 after acquiring an additional 624 shares in the last quarter. Finally, CX Institutional grew its position in shares of Healthpeak Properties by 6.1% during the 2nd quarter. CX Institutional now owns 11,003 shares of the real estate investment trust's stock valued at $235,000 after acquiring an additional 633 shares during the period. Hedge funds and other institutional investors own 93.57% of the company's stock.
Healthpeak Properties Company Profile
(
Get Free Report)
Healthpeak Properties, Inc. is a real estate investment trust that owns and operates properties serving the healthcare and life sciences industries. Its portfolio includes outpatient medical buildings, life science facilities and senior housing communities. The company's properties are located across the United States, with investments in major healthcare and life science markets. In 2024, Healthpeak completed its merger with Physicians Realty Trust, expanding its portfolio of outpatient medical properties.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.